Department of Urology, Temple University School of Medicine, Philadelphia, Pennsylvania; Department of Otolaryngology (JCL), Temple University School of Medicine, Philadelphia, Pennsylvania.
Department of Urology, Temple University School of Medicine, Philadelphia, Pennsylvania; Department of Otolaryngology (JCL), Temple University School of Medicine, Philadelphia, Pennsylvania.
J Urol. 2017 Dec;198(6):1430-1435. doi: 10.1016/j.juro.2017.06.097. Epub 2017 Jul 20.
Surgical management of proximal and mid ureteral strictures that are not amenable to primary excision and anastomosis is challenging. Although a buccal mucosa graft is commonly used during substitution urethroplasty, its use in substitution ureteroplasty is limited. We describe our technique of robotic ureteroplasty with a buccal mucosa graft to manage complex ureteral strictures and we report our outcomes.
We retrospectively reviewed the records of 12 patients who underwent robotic ureteroplasty with a buccal mucosa graft between September 2014 and June 2016. The indication for the procedure was a proximal or mid ureteral stricture not amenable to primary excision and anastomosis. The primary outcomes were clinical success, absent symptoms on ureteral pathology and radiological success, defined as absent ureteral obstruction on retrograde pyelography, renal scan and/or computerized tomography.
Four of the 12 patients (33.3%) had a ureteropelvic junction stricture, 4 (33.3%) had a proximal stricture and 4 (33.3%) had a mid ureteral stricture. Eight of the 12 patients (66.7%) had previously undergone failed ureteral reconstruction. Median stricture length was 3 cm (range 2 to 5). Median operative time was 217 minutes (range 136 to 344) and mean estimated blood loss was 100 ml (range 50 to 200). Median length of stay was 1 day (range 1 to 6). At a median followup of 13 months (range 4 to 30) 10 of the 12 cases (83.3%) were clinically and radiologically successful.
Robotic ureteroplasty with a buccal mucosa graft is associated with low inherent morbidity. It is an effective way to manage complex proximal and mid ureteral strictures.
对于无法进行原发性切除和吻合的近端和中段输尿管狭窄,手术治疗具有挑战性。虽然在替代尿道成形术中通常使用颊黏膜移植物,但在替代输尿管成形术中其应用受限。我们描述了使用颊黏膜移植物进行机器人输尿管成形术来治疗复杂输尿管狭窄的技术,并报告了我们的结果。
我们回顾性分析了 2014 年 9 月至 2016 年 6 月期间 12 例接受机器人输尿管成形术和颊黏膜移植物的患者的记录。该手术的适应证为近端或中段输尿管狭窄,无法进行原发性切除和吻合。主要结果是临床成功(输尿管病理无症状)和放射学成功(逆行肾盂造影、肾扫描和/或计算机断层扫描未见输尿管梗阻)。
12 例患者中 4 例(33.3%)患有肾盂输尿管连接部狭窄,4 例(33.3%)患有近端狭窄,4 例(33.3%)患有中段输尿管狭窄。12 例患者中有 8 例(66.7%)曾行失败的输尿管重建术。中位狭窄长度为 3cm(范围 2 至 5cm)。中位手术时间为 217 分钟(范围 136 至 344 分钟),平均估计失血量为 100ml(范围 50 至 200ml)。中位住院时间为 1 天(范围 1 至 6 天)。中位随访 13 个月(范围 4 至 30 个月)后,12 例中的 10 例(83.3%)在临床和放射学上均获得成功。
机器人输尿管成形术联合颊黏膜移植物具有较低的固有发病率。它是治疗复杂的近端和中段输尿管狭窄的有效方法。